BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnson ME, Stringer A, Bobrovskaya L. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson’s disease. NeuroToxicology 2018;65:174-85. [DOI: 10.1016/j.neuro.2018.02.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Ding W, Xu Y, Li S, Zhang W. Exploratory application of an integrated topic-based curriculum in biochemistry experimental teaching. Biochem Mol Biol Educ 2022. [PMID: 36082801 DOI: 10.1002/bmb.21564] [Reference Citation Analysis]
2 Han X, Han B, Zhao Y, Li G, Wang T, He J, Du W, Cao X, Gan J, Wang Z, Zheng W. Rosmarinic Acid Attenuates Rotenone-Induced Neurotoxicity in SH-SY5Y Parkinson’s Disease Cell Model through Abl Inhibition. Nutrients 2022;14:3508. [DOI: 10.3390/nu14173508] [Reference Citation Analysis]
3 Rahman Z, Dandekar MP. Implication of Paraprobiotics in Age-Associated Gut Dysbiosis and Neurodegenerative Diseases. Neuromolecular Med 2022. [PMID: 35879588 DOI: 10.1007/s12017-022-08722-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tan AH, Lim SY, Lang AE. The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic. Nat Rev Neurol 2022. [PMID: 35750883 DOI: 10.1038/s41582-022-00681-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
5 Moon SH, Kwon Y, Huh YE, Choi HJ. Trehalose ameliorates prodromal non-motor deficits and aberrant protein accumulation in a rotenone-induced mouse model of Parkinson's disease. Arch Pharm Res 2022. [PMID: 35618982 DOI: 10.1007/s12272-022-01386-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Safarpour D, Sharzehi K, Pfeiffer RF. Gastrointestinal Dysfunction in Parkinson’s Disease. Drugs. [DOI: 10.1007/s40265-021-01664-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Mohamad KA, El-Naga RN, Wahdan SA. Neuroprotective effects of indole-3-carbinol on the rotenone rat model of Parkinson's disease: Impact of the SIRT1-AMPK signaling pathway. Toxicol Appl Pharmacol 2022;435:115853. [PMID: 34973289 DOI: 10.1016/j.taap.2021.115853] [Reference Citation Analysis]
8 Li Y, Chen Y, Jiang L, Zhang J, Tong X, Chen D, Le W. Intestinal Inflammation and Parkinson's Disease. Aging Dis 2021;12:2052-68. [PMID: 34881085 DOI: 10.14336/AD.2021.0418] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Lama J, Buhidma Y, Fletcher E, Duty S. Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research. Neuronal Signaling 2021;5:NS20210026. [DOI: 10.1042/ns20210026] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 2021;9:226. [PMID: 34784980 DOI: 10.1186/s40168-021-01107-9] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
11 De Miranda BR, Goldman SM, Miller GW, Greenamyre JT, Dorsey ER. Preventing Parkinson's Disease: An Environmental Agenda. J Parkinsons Dis 2021. [PMID: 34719434 DOI: 10.3233/JPD-212922] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
12 Ilie OD, Paduraru E, Robea MA, Balmus IM, Jijie R, Nicoara M, Ciobica A, Nita IB, Dobrin R, Doroftei B. The Possible Role of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 on Locomotor Activity and Oxidative Stress in a Rotenone-Induced Zebrafish Model of Parkinson's Disease. Oxid Med Cell Longev 2021;2021:9629102. [PMID: 34691361 DOI: 10.1155/2021/9629102] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zhao Z, Li F, Ning J, Peng R, Shang J, Liu H, Shang M, Bao XQ, Zhang D. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota-gut-brain axis. Acta Pharm Sin B 2021;11:2859-79. [PMID: 34589401 DOI: 10.1016/j.apsb.2021.03.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Socała K, Doboszewska U, Szopa A, Serefko A, Włodarczyk M, Zielińska A, Poleszak E, Fichna J, Wlaź P. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res 2021;172:105840. [PMID: 34450312 DOI: 10.1016/j.phrs.2021.105840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
15 Natale G, Ryskalin L, Morucci G, Lazzeri G, Frati A, Fornai F. The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson's Disease. Life (Basel) 2021;11:732. [PMID: 34440476 DOI: 10.3390/life11080732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Choi YJ, Kim JE, Lee SJ, Gong JE, Son HJ, Hong JT, Hwang DY. Dysbiosis of Fecal Microbiota From Complement 3 Knockout Mice With Constipation Phenotypes Contributes to Development of Defecation Delay. Front Physiol 2021;12:650789. [PMID: 34349661 DOI: 10.3389/fphys.2021.650789] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
17 Fang P, Kazmi SA, Jameson KG, Hsiao EY. The Microbiome as a Modifier of Neurodegenerative Disease Risk. Cell Host Microbe 2020;28:201-22. [PMID: 32791113 DOI: 10.1016/j.chom.2020.06.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 43] [Article Influence: 11.0] [Reference Citation Analysis]
18 Innos J, Hickey MA. Using Rotenone to Model Parkinson's Disease in Mice: A Review of the Role of Pharmacokinetics. Chem Res Toxicol 2021;34:1223-39. [PMID: 33961406 DOI: 10.1021/acs.chemrestox.0c00522] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
19 Izco M, Vettorazzi A, Forcen R, Blesa J, de Toro M, Alvarez-Herrera N, Cooper JM, Gonzalez-Peñas E, Lopez de Cerain A, Alvarez-Erviti L. Oral subchronic exposure to the mycotoxin ochratoxin A induces key pathological features of Parkinson's disease in mice six months after the end of the treatment. Food Chem Toxicol 2021;152:112164. [PMID: 33819549 DOI: 10.1016/j.fct.2021.112164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
20 Bhattarai Y, Si J, Pu M, Ross OA, McLean PJ, Till L, Moor W, Grover M, Kandimalla KK, Margolis KG, Farrugia G, Kashyap PC. Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson's disease. Gut Microbes 2021;13:1866974. [PMID: 33459114 DOI: 10.1080/19490976.2020.1866974] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 23.0] [Reference Citation Analysis]
21 Albuquerque JCS, Mendes TS, BrandÃo MGSA, Frota AF, Reis TDSD, Aguiar LMV, GraÇa JRVD. STRUCTURAL BASES OF GASTROINTESTINAL MOTILITY CHANGES IN PARKINSON'S DISEASE: STUDY IN RATS. Arq Bras Cir Dig 2021;33:e1548. [PMID: 33470378 DOI: 10.1590/0102-672020200003e1548] [Reference Citation Analysis]
22 Rani L, Mondal AC. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications. Neurosci Res 2021;168:100-12. [PMID: 33417973 DOI: 10.1016/j.neures.2021.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
23 Kang Y, Kang X, Zhang H, Liu Q, Yang H, Fan W. Gut Microbiota and Parkinson's Disease: Implications for Faecal Microbiota Transplantation Therapy. ASN Neuro 2021;13:17590914211016217. [PMID: 34053243 DOI: 10.1177/17590914211016217] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
24 Song S, Liu J, Zhang F, Hong JS. Norepinephrine depleting toxin DSP-4 and LPS alter gut microbiota and induce neurotoxicity in α-synuclein mutant mice. Sci Rep 2020;10:15054. [PMID: 32929122 DOI: 10.1038/s41598-020-72202-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Pfeiffer RF, Isaacson SH, Pahwa R. Clinical implications of gastric complications on levodopa treatment in Parkinson's disease. Parkinsonism Relat Disord 2020;76:63-71. [PMID: 32461054 DOI: 10.1016/j.parkreldis.2020.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
26 Mendonça IP, Duarte-Silva E, Chaves-Filho AJM, Andrade da Costa BLDS, Peixoto CA. Neurobiological findings underlying depressive behavior in Parkinson's disease: A review. Int Immunopharmacol 2020;83:106434. [PMID: 32224442 DOI: 10.1016/j.intimp.2020.106434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
27 Xu Y, Xie M, Xue J, Xiang L, Li Y, Xiao J, Xiao G, Wang HL. EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson's disease. FASEB J 2020;34:5931-50. [PMID: 32157731 DOI: 10.1096/fj.201903125RR] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
28 Hu AL, Song S, Li Y, Xu SF, Zhang F, Li C, Liu J. Mercury sulfide-containing Hua-Feng-Dan and 70W (Rannasangpei) protect against LPS plus MPTP-induced neurotoxicity and disturbance of gut microbiota in mice. J Ethnopharmacol 2020;254:112674. [PMID: 32105745 DOI: 10.1016/j.jep.2020.112674] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
29 Chen C, Zhang B, Hu A, Li H, Liu J, Zhang F. Protective role of cinnabar and realgar in Hua-Feng-Dan against LPS plus rotenone-induced neurotoxicity and disturbance of gut microbiota in rats. Journal of Ethnopharmacology 2020;247:112299. [DOI: 10.1016/j.jep.2019.112299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
30 Jackson A, Forsyth CB, Shaikh M, Voigt RM, Engen PA, Ramirez V, Keshavarzian A. Diet in Parkinson's Disease: Critical Role for the Microbiome. Front Neurol 2019;10:1245. [PMID: 31920905 DOI: 10.3389/fneur.2019.01245] [Cited by in Crossref: 23] [Cited by in F6Publishing: 46] [Article Influence: 7.7] [Reference Citation Analysis]
31 Chen Z, Li G, Liu J. Autonomic dysfunction in Parkinson's disease: Implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis 2020;134:104700. [PMID: 31809788 DOI: 10.1016/j.nbd.2019.104700] [Cited by in Crossref: 23] [Cited by in F6Publishing: 46] [Article Influence: 7.7] [Reference Citation Analysis]
32 Chen ZZ, Niu YY. Stem cell therapy for Parkinson's disease using non-human primate models. Zool Res 2019;40:349-57. [PMID: 31343853 DOI: 10.24272/j.issn.2095-8137.2019.053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
33 Bullich C, Keshavarzian A, Garssen J, Kraneveld A, Perez-Pardo P. Gut Vibes in Parkinson's Disease: The Microbiota-Gut-Brain Axis. Mov Disord Clin Pract 2019;6:639-51. [PMID: 31745471 DOI: 10.1002/mdc3.12840] [Cited by in Crossref: 20] [Cited by in F6Publishing: 31] [Article Influence: 6.7] [Reference Citation Analysis]
34 Chen H, Ritz B. The Search for Environmental Causes of Parkinson's Disease: Moving Forward. J Parkinsons Dis 2018;8:S9-S17. [PMID: 30584168 DOI: 10.3233/JPD-181493] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
35 Dempsey JL, Little M, Cui JY. Gut microbiome: An intermediary to neurotoxicity. Neurotoxicology 2019;75:41-69. [PMID: 31454513 DOI: 10.1016/j.neuro.2019.08.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
36 Gazerani P. Probiotics for Parkinson's Disease. Int J Mol Sci 2019;20:E4121. [PMID: 31450864 DOI: 10.3390/ijms20174121] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
37 Gorecki AM, Preskey L, Bakeberg MC, Kenna JE, Gildenhuys C, MacDougall G, Dunlop SA, Mastaglia FL, Akkari PA, Koengten F, Anderton RS. Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model. Front Neurosci 2019;13:839. [PMID: 31440136 DOI: 10.3389/fnins.2019.00839] [Cited by in Crossref: 48] [Cited by in F6Publishing: 65] [Article Influence: 16.0] [Reference Citation Analysis]
38 Zhang BB, Liu YM, Hu AL, Xu SF, Fan LD, Cheng ML, Li C, Wei LX, Liu J. HgS and Zuotai differ from HgCl2 and methyl mercury in intestinal Hg absorption, transporter expression and gut microbiome in mice. Toxicol Appl Pharmacol 2019;379:114615. [PMID: 31175882 DOI: 10.1016/j.taap.2019.114615] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
39 Miraglia F, Colla E. Microbiome, Parkinson's Disease and Molecular Mimicry. Cells 2019;8:E222. [PMID: 30866550 DOI: 10.3390/cells8030222] [Cited by in Crossref: 24] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
40 Johnson ME, Zhou XF, Bobrovskaya L. The effects of rotenone on TH, BDNF and BDNF-related proteins in the brain and periphery: Relevance to early Parkinson's disease. J Chem Neuroanat 2019;97:23-32. [PMID: 30690135 DOI: 10.1016/j.jchemneu.2019.01.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
41 Radisavljevic N, Cirstea M, Brett Finlay B. Bottoms up: the role of gut microbiota in brain health. Environ Microbiol 2018. [PMID: 30556271 DOI: 10.1111/1462-2920.14506] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
42 Perez-pardo P, Dodiya H, Engen P, Naqib A, Forsyth C, Green S, Garssen J, Keshavarzian A, Kraneveld A. Gut bacterial composition in a mouse model of Parkinson’s disease. Beneficial Microbes 2018;9:799-814. [DOI: 10.3920/bm2017.0202] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
43 Sun MF, Shen YQ. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease. Ageing Res Rev 2018;45:53-61. [PMID: 29705121 DOI: 10.1016/j.arr.2018.04.004] [Cited by in Crossref: 136] [Cited by in F6Publishing: 141] [Article Influence: 34.0] [Reference Citation Analysis]